BARCELONA, Spain, Feb. 27, 2026 /PRNewswire/ — MWC 2026 (Hall 5, 5L24MR & 5L26MR) – Metanoia today unveiled major commercial momentum behind its MT2824 “Cobra” BARCELONA, Spain, Feb. 27, 2026 /PRNewswire/ — MWC 2026 (Hall 5, 5L24MR & 5L26MR) – Metanoia today unveiled major commercial momentum behind its MT2824 “Cobra”

Metanoia Ignites Open RAN Disruption at MWC 2026 with Open SDR Platform for AI-Driven 5G

2026/02/27 17:30
2 min read
For feedback or concerns regarding this content, please contact us at [email protected]

BARCELONA, Spain, Feb. 27, 2026 /PRNewswire/ — MWC 2026 (Hall 5, 5L24MR & 5L26MR) – Metanoia today unveiled major commercial momentum behind its MT2824 “Cobra” 5G SoC and MOSART Open Foundation Software Defined Radio (SDR) platform, redefining the economics of FR1 and FR2 radio infrastructure.

As operators race to support Edge AI and massive connectivity, Metanoia is enabling ODMs to dramatically reduce development time, lower system costs, and eliminate proprietary software lock-in.

Open Architecture. Faster Time-to-Market. Real Design Wins.

Built around the high-performance MT2824 baseband SoC, Metanoia delivers a semi-turnkey Open RAN solution aligned with O-RAN WG7 “white box” architecture, including:

  • 4T4R 24 dBm Indoor ORU
  • 4T4R 5W & 15W FR1 Outdoor ORUs
  • MSO-optimized Strand-Mount ORU
  • 50 dBm FR2 Outdoor Radio (FWA & Private Networks)

Metanoia provides complete Hardware Design Kits (HDK) and a comprehensive Software Development Kit (SDK), enabling ODMs to move from concept to commercial deployment at unprecedented speed.

The company has already secured multiple design wins across public, private, and MSO network segments.

MOSART: Breaking the Software Lock-In Cycle

At the core of the platform is MOSART (Metanoia Open Source Advanced Radio Technology) — a managed Open Foundation Linux-based SDR stack that runs on MT2824 and other Linux-capable platforms.

Combined with MRAS DSP acceleration, MOSART allows ODMs to own their feature roadmap, lifecycle management, and security — freeing them from proprietary software dependency.

“We believe Software Defined Radio is the key to unlocking affordable, scalable wireless access,” said Stewart Wu, CEO of Metanoia. “Our open MOSART model gives ODMs and operators control back — while enabling the AI-driven edge networks of tomorrow.”

Metanoia is showcasing FR1 and FR2 development platforms and ORAN-aligned reference radios at MWC 2026, Hall 5 (5L24MR & 5L26MR).

About Metanoia

Metanoia Communications Inc. is headquartered in Hsinchu Science Park, Taiwan, specializing in Software Defined Radio (SDR) SoC solutions for 5G Open RAN Radio Units and small cells. Metanoia enables partners to accelerate radio development with integrated, power-efficient silicon designed for next-generation networks.

Contact: Calvin Wu/Business Development [email protected]

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/metanoia-ignites-open-ran-disruption-at-mwc-2026-with-open-sdr-platform-for-ai-driven-5g-302698322.html

SOURCE Metanoia Communications Inc.

Market Opportunity
SedraCoin Logo
SedraCoin Price(SDR)
$0.00000169
$0.00000169$0.00000169
-0.58%
USD
SedraCoin (SDR) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.
Tags:

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09